Table: Kaken Pharmaceutical - 9-MTH group results

KAKEN PHARMACEUTICAL

06/02/2025 06:31

Feb 6 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2024        Dec 31, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             75.99               54.69            88.50    
                 (+39.0 pct)         (-1.6 pct)       (+22.8 pct) 
  Operating         25.42                8.87            20.80    
                (+186.5 pct)         (-28.4 pct)     (+118.6 pct) 
  Recurring         26.08                9.30            21.20    
                (+180.3 pct)         (-28.3 pct)     (+113.0 pct) 
  Net               19.18                6.68            14.20    
                (+187.2 pct)         (-27.0 pct)      (+76.9 pct) 
  EPS            506.31 yen          177.10 yen       374.93 yen  
  Ann Div                            150.00 yen       190.00 yen  
  -Q2 div        115.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T